This report contains market size and forecasts of Selective Agonists in Global, including the following market information:
Global Selective Agonists Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Selective Agonists market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
α1 Selective Agonists Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Selective Agonists include Merck, Bausch Health Companies, Pfizer, Sterling Winthrop, Sanofi, Paragon BioTeck, West-Ward Pharmaceuticals , Biosyent Pharma  and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Selective Agonists companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Selective Agonists Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Selective Agonists Market Segment Percentages, by Type, 2021 (%)
α1 Selective Agonists
α2 Selective Agonists
β1 Selective Agonists
β2 Selective Agonists
Global Selective Agonists Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Selective Agonists Market Segment Percentages, by Application, 2021 (%)
Paroxysmal Supraventricular Tachycardia
Eye Drops
Anaphylaxis
Cardiac Arrest
Anaphylaxis
Cardiac Arrest
Chronic Heart Failure
Myocardial Infarction
Postoperative Hypotension
Global Selective Agonists Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Selective Agonists Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Selective Agonists revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Selective Agonists revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Bausch Health Companies
Pfizer
Sterling Winthrop
Sanofi
Paragon BioTeck
West-Ward Pharmaceuticals 
Biosyent Pharma 
Novartis
Omega Laboratories
Medical Purchasing Solutions
Avadel Legacy Pharmaceuticals
Amneal Biosciences
Cipla USA
Par Pharmaceutical
Glaxosmithkline
Teva
Bayer
Impax Generics
Mylan Pharmaceuticals
Physicians Total Care
Cadila Pharnmaceuticals
Alembic Pharmaceuticals
Allergan
Mylan